Dec 5 Agenda Notes
2015-01-13azim58 - Dec 5 Agenda Notes
Welcome to DNA Vaccines 2012
David B. Weiner, PhD
Professor, University of Pennsylvania
helped found the field of DNA vaccines. Focuses on HIV
The Future of Malaria Vaccines
Chairs: Ashley Birkett & Niranjan Sardesai
Ashley is a guy from UK working on Malaria vaccines
/*
Niranjan Sardesai
Cheif operating officer of Inovio Pharmaceutical; they make synco
vaccines; working on universal flu vaccines among other things
- /
9:30 AM - 10:00 AM
Robust CD8+ T-Cell-Dependent IFN-Gamma Responses Against Restricted
Domains on P. Falciparum Antigens Induced by a DNA- Prime-Adenovector
Boost Vaccine Regimen are Associated with Protection Against Sporozoite
Challenge
Martha Sedegah, PhD
Senior Scientist & Director, Clinical Immunology Malaria Program, Navy
Component, U. S. Military Malaria Vaccine Program
10:00 AM - 10:30 AM
From the Bench to the Clinic: Development of Viral Vector-Based
Blood-Stage Malaria Vaccines
Sumi Biswas, DPhil
Group Leader/Post Doctoral Scientist, The Jenner Institute
located in at Oxford
Frontiers in Vaccine Research
Chairs: Matti Sällberg & Martha Sedegah
/*
Matti Sällberg
focuses on hepatotropic viruses; from the Karolinska Institute in Sweden
Martha was already on agenda
- /
11:00 AM - 11:30 AM
Therapeutic Indications for DNA Vaccines
Tony Ford Hutchinson, PhD
President, Ford-Hutchinson Consulting Ltd
located in Pennsylvania
11:30 AM - 12:00 PM
What is the Role of Therapeutic Vaccination in the Era of Directly Acting
Antivirals in the Therapy of Hepatitis C
Matti Sällberg, PhD
Board Member & Consultant, Tripep AB
Professor, Karolinska Institutet
12:00 PM - 12:30 PM
Tuberculosis Vaccines
David Hokey, PhD
Director of Immunology, Aeras
in Maryland. Aeras produces many constructs, assesses the immune response
induced by candidate vaccines
Cutting Edge RNA Technologies
Chairs: Peter Liljeström & Andrew Geall
Peter Liljeström from Karolinska Institute in Sweden
Andrew Geall
RNA Vaccine Platform Leader at Novartis
Novartis is a Swiss multinational pharmaceutical company
1:45 PM - 2:10 PM
DNA/RNA Replicon Vaccines
Peter Liljeström, PhD
Professor of Infectious Disease Control, Karolinska Institutet
A Replicon in genetics is a region of DNA or RNA, that replicates from a
single origin of replication.
2:10 PM - 2:35 PM
Non-Viral Delivery of Self-Amplifying RNA Vaccines
Andrew Geall, PhD
RNA Vaccine Platform Technology Leader, Novartis Vaccines & Diagnostics
2:35 PM - 3:00 PM
Development of Therapeutic and Prophylactic Vaccines
Karl-Josef Kallen, MD, PhD
Chief Scientific & Chief Medical Officer, CureVac GmbH
CureVac slogan (the RNA people)
uses medical potential of messenger RNA
located in Tubingen Germany
gmbh is a german acronym that translates to a company with limited
liability
Abstract Session
Chairs: Anne De Groot & Amir Khan
Anne De Groot
expert in epitope driven vaccines at Brown University (at Providence
Rhode Island)
she is also CEO of EpiVax
Amir Khan
an epidemiologist based in Karachi Pakistan
Aamir is an Associate at the Johns Hopkins Bloomberg School of Public
Health and an Adjunct Associate Professor of Global Health at the
University of Texas Health Science Center.
Founder and Executive Director of IRD (interactive research and
development or something that works in poorer countries)
Aamir directs the Indus Hospital’s
3:30 PM - 3:45 PM
A Multi-agent Encephalitic Alphavirus DNA Vaccine Delivered by
Electroporation Elicits Protective Immunity against Aerosol Challenge
with Eastern and Western Equine Encephalitis Viruses in Nonhuman Primates
Drew Hannaman - Vice President, Ichor Medical Systems, Inc.
Ichor is located in San Diego California
3:45 PM - 4:00 PM
Inducing Potent Humoral and Cellular Responses to Multiple Sporozoite and
Liver-Stage Malaria Antigens Using pDNA
Bernadette Ferraro, PhD, MPH
Postdoctoral Fellow, University of Pennsylvania
Ferraro may be a Portuguese name
4:00 PM - 4:15 PM
Development of a Novel DNA Vaccine Strategy for Prevention of Clostridium
Difficile Infection
Michele A. Kutzler, PhD
Assistant Professor, Drexel University College of Medicine
located in Philadelphia
4:15 PM - 4:30 PM
NF-ĸB Activation Mediates Tumor-Specific CTL Responses Elicited by DNA
Vaccines
Maarten Ligtenberg
PhD Candidate, Karolinska Institutet
located in Sweden
4:30 PM - 5:30 PM
Plenary Roundtable I - Chairs: John Sterling & David Weiner Development
and Commercialization of Novel Vaccines
Ashley Birkett
Tony Ford Hutchinson
Niranjan Sardesai
Jeffrey Ulmer//
Jeffrey Ulmer
Global Head, External Research at Novartis